Research programme: G-protein coupled receptors targeting radiopharmaceuticals - Radionetics Oncology
Latest Information Update: 16 Feb 2024
At a glance
- Originator Radionetics Oncology
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals; Small molecules
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer